Related references
Note: Only part of the references are listed.Long-term survival and postoperative complications of pre-liver transplantation transarterial chemoembolisation in hepatocellular carcinoma: A systematic review and meta-analysis
Daniel A. Butcher et al.
EJSO (2022)
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation
Quirino Lai et al.
FRONTIERS IN ONCOLOGY (2022)
Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
Laura Crocetti et al.
CANCERS (2021)
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma Analysis From the US Multicenter HCC Transplant Consortium
Joseph DiNorcia et al.
ANNALS OF SURGERY (2020)
Liver transplantation for hepatocellular carcinoma: Management after the transplant
Elizabeth C. Verna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post-transplant Clinical Outcome
Nia Adeniji et al.
CLINICAL TRANSPLANTATION (2020)
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation
Quirino Lai et al.
LIVER TRANSPLANTATION (2019)
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
Laura Kulik et al.
HEPATOLOGY (2018)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study
Neil Mehta et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Which Is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?
Quirino Lai et al.
ANNALS OF SURGERY (2018)
The Impact of Bridging LRT on Survival in Patients Listed for Liver Transplantation
Peiman Habibollahi et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma
Minzhi Xing et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Bridging locoregional therapy: Longitudinal trends and outcomes in patients with hepatocellular carcinoma
Hayley C. Oligane et al.
TRANSPLANTATION REVIEWS (2017)
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium
Vatche G. Agopian et al.
ANNALS OF SURGERY (2017)
Reassessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand With Tumor Down-Staging?
Francis Y. Yao et al.
HEPATOLOGY (2016)
Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
Francis Y. Yao et al.
HEPATOLOGY (2015)
Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma
Emmanuel Tsochatzis et al.
LIVER INTERNATIONAL (2013)
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction
Elisabeth R. Garwood et al.
LIVER TRANSPLANTATION (2013)
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation
Maurizio Pompili et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Effectiveness of Locoregional Therapy Before Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma Who Meet the Milan Criteria
J. M. Kim et al.
TRANSPLANTATION PROCEEDINGS (2012)
Chemoembolization Decreases Drop-Off Risk of Hepatocellular Carcinoma Patients on the Liver Transplant List
Constantine Frangakis et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Priority of Candidates With Hepatocellular Carcinoma Awaiting Liver Transplantation Can Be Reduced After Successful Bridge Therapy
Alessandro Cucchetti et al.
LIVER TRANSPLANTATION (2011)
Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation
Derek A. DuBay et al.
HPB (2011)
Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
K. Washburn et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
The survival benefit of liver transplantation in hepatocellular carcinoma patients
Umberto Cillo et al.
DIGESTIVE AND LIVER DISEASE (2010)
Report of a National conference on Liver Allocation in Patients with Hepatocellular Carcinoma in the United States
Elizabeth A. Pomfret et al.
LIVER TRANSPLANTATION (2010)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Percutaneous ethanol injection before liver transplantation in the hepatocellular carcinoma
Fernanda Branco et al.
ANNALS OF HEPATOLOGY (2009)
Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
RH Wiesner et al.
GASTROENTEROLOGY (2004)
Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list
FY Yao et al.
LIVER TRANSPLANTATION (2002)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
